| Literature DB >> 32282650 |
Kathryn Bradford1, Alexander Nobori2, Brittany Johnson3, Wendy Allen-Rhoades4, Bindi Naik-Mathuria3, Eduard H Panosyan5, Moran Gotesman5, Joseph Lasky5,6, Jerry Cheng7, Alan Ikeda6, Jeffrey Goldstein2, Arun Singh8, Noah Federman1.
Abstract
The Ewing sarcoma family of tumors (ESFT) are high-grade small round blue cell malignancies traditionally presenting in children and adolescents. The most common site of primary disease is bone, though extraskeletal primary sites are well-recognized. We present 6 cases of primary ESFT of the kidney and 1 case of the adrenal gland. Patients were 11 to 18 years of age at diagnosis. Metastases at diagnosis were present in most cases (n=6). All patients underwent surgery, and most received radiation (n=5). Five patients relapsed after initial remission. Comprehensive review of the primary renal ESFT literature was used to analyze various factors, including age, sex, disease metrics, metastases at diagnoses, and overall survival in a total of 362 cases. Notably, while the general ESFT population has reported rates of metastasis at diagnosis of 20% to 25%, this rate in the renal ESFT population was 53% with a rate of 59% in adolescent and young-adult patients (11 to 24 y). Nodal disease at diagnosis was present in 24% of renal ESFT cases compared with 3.2% in patients with primary skeletal ESFT. While this malignant process may share histologic and molecular features with its bone and soft tissue counterparts, primary renal ESFT presentations seem to be more aggressive and have worse outcomes.Entities:
Mesh:
Year: 2020 PMID: 32282650 PMCID: PMC7554078 DOI: 10.1097/MPH.0000000000001804
Source DB: PubMed Journal: J Pediatr Hematol Oncol ISSN: 1077-4114 Impact factor: 1.170